Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The issues in autologous transfusion.

T L Simon1, K J Smith

  • 1Department of Pathology, School of Medicine, University of New Mexico, Albuquerque 87131.

Human Pathology
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ventilatory and cerebrovascular responses to exercise in lowlander children acclimatizing to high-altitude.

The Journal of physiology·2025
Same author

Tricuspid chordae tendineae mechanics: Insertion site, leaflet, and size-specific analysis and constitutive modelling.

Shi yan li xue = Journal of experimental mechanics·2024
Same author

Cardiopulmonary and cerebrovascular acclimatization in children and adults at 3800 m.

The Journal of physiology·2022
Same author

Efficacy of bivalent fimbrial vaccines to control and eliminate intermediate forms of footrot in sheep.

Australian veterinary journal·2021
Same author

Cost-effectiveness analysis of tumor molecular classification in high-risk early-stage endometrial cancer.

Gynecologic oncology·2021
Same author

The severity of footrot lesions induced by aprV2-positive strains of Dichelobacter nodosus varies between strains.

Australian veterinary journal·2021
Same journal

Clinical Impact of Second Opinion Consultation in Bladder Biopsies and Transurethral Resection of Bladder Tumors.

Human pathology·2026
Same journal

Prognostic relevance and molecular correlates of Claudin-1 expression in pancreatic neuroendocrine tumors.

Human pathology·2026
Same journal

Mixed Phenotype Acute Leukemia: Lineage Assignment, Immunophenotypic Classification and Genetic Insights.

Human pathology·2026
Same journal

Chronic myelomonocytic leukemia revisited: A comprehensive review with emphasis on the oligomonocytic subtype.

Human pathology·2026
Same journal

Artificial intelligence-assisted screening for NTRK fusion-positive salivary gland tumors: A novel digital pathology workflow.

Human pathology·2026
Same journal

Evaluation of prognostic factors and outcomes in primary versus secondary myeloid sarcoma.

Human pathology·2026
See all related articles

Autologous transfusion offers safer blood therapy for eligible patients undergoing elective surgery. Patients receive iron supplements and donate blood weekly, with the last donation 72 hours before their procedure.

Area of Science:

  • Transfusion Medicine
  • Surgical Safety
  • Patient Blood Management

Background:

  • Autologous transfusion is a safe alternative to allogeneic blood transfusions.
  • Patient selection and preparation are crucial for successful autologous blood donation.

Purpose of the Study:

  • To outline guidelines for autologous transfusion in elective surgery.
  • To emphasize patient and physician education on autologous transfusion benefits.

Main Methods:

  • Patient eligibility criteria include good general health, no contraindications, and likelihood of transfusion.
  • Pre-donation iron supplementation and weekly donations are recommended.
  • Donations occur weekly, with the last unit collected at least 72 hours before surgery.

Related Experiment Videos

Main Results:

  • Autologous transfusion can be safely implemented in selected patients.
  • Specific protocols for donation frequency, timing, and patient preparation are outlined.
  • Safeguards for identification and processing are essential.

Conclusions:

  • Autologous transfusion should be promoted as a safer transfusion option.
  • Further research is needed on erythropoietin use, contraindications, and cost-effectiveness.
  • Education for the public, physicians, and payers is vital for wider adoption.